Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wim Jiskoot

Showing results (21-30 of 278) with videos related to

Pageof 28
Sort By:
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 14, 2013
Triethylenetetramine prevents insulin aggregation and fragmentation during copper catalyzed oxidationRiccardo Torosantucci, Daniel Weinbuch, Robin Klem, et al.
Journal of Pharmaceutical Sciences|August 23, 2012
Asymmetrical flow field-flow fractionation method for the analysis of submicron protein aggregatesAndrea Hawe, Stefan Romeijn, Vasco Filipe, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 28, 2021
Claiming therapeutic protein stability in a clinical setting based on limited analytical data is misleading and dangerousRoderick van den Berg, Enrico Mastrobattista, Wim Jiskoot
Pharmaceutical Research|March 26, 2017
Formulation, Delivery and Stability of Bone Morphogenetic Proteins for Effective Bone RegenerationInas El Bialy, Wim Jiskoot, M Reza Nejadnik
Trends in Pharmacological Sciences|December 8, 2009
Immunological mechanism underlying the immune response to recombinant human protein therapeuticsMelody Sauerborn, Vera Brinks, Wim Jiskoot, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 21, 2012
Microneedle technologies for (trans)dermal drug and vaccine deliveryKoen van der Maaden, Wim Jiskoot, Joke Bouwstra
Journal of Pharmaceutical Sciences|April 21, 2012
Transient molten globules and metastable aggregates induced by brief exposure of a monoclonal IgG to low pHVasco Filipe, Başak Kükrer, Andrea Hawe, et al.
Pharmaceutical Research|October 26, 2017
Nanoparticulate Impurities Isolated from Pharmaceutical-Grade Sucrose Are a Potential Threat to Protein StabilityDaniel Weinbuch, Mitchel Ruigrok, Wim Jiskoot, et al.
Analytical Biochemistry|May 6, 2008
Online fluorescent dye detection method for the characterization of immunoglobulin G aggregation by size exclusion chromatography and asymmetrical flow field flow fractionationAndrea Hawe, Wolfgang Friess, Marc Sutter, et al.
Cytokine & Growth Factor Reviews|October 8, 2021
The interleukin-1 cytokine family members: Role in cancer pathogenesis and potential therapeutic applications in cancer immunotherapyBart Boersma, Wim Jiskoot, Peter Lowe, et al.
Pageof 28

Showing results (21-30 of 278) with videos related to

Sort By:
Pageof 28
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 14, 2013
Triethylenetetramine prevents insulin aggregation and fragmentation during copper catalyzed oxidationRiccardo Torosantucci, Daniel Weinbuch, Robin Klem, et al.
Journal of Pharmaceutical Sciences|August 23, 2012
Asymmetrical flow field-flow fractionation method for the analysis of submicron protein aggregatesAndrea Hawe, Stefan Romeijn, Vasco Filipe, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 28, 2021
Claiming therapeutic protein stability in a clinical setting based on limited analytical data is misleading and dangerousRoderick van den Berg, Enrico Mastrobattista, Wim Jiskoot
Pharmaceutical Research|March 26, 2017
Formulation, Delivery and Stability of Bone Morphogenetic Proteins for Effective Bone RegenerationInas El Bialy, Wim Jiskoot, M Reza Nejadnik
Trends in Pharmacological Sciences|December 8, 2009
Immunological mechanism underlying the immune response to recombinant human protein therapeuticsMelody Sauerborn, Vera Brinks, Wim Jiskoot, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 21, 2012
Microneedle technologies for (trans)dermal drug and vaccine deliveryKoen van der Maaden, Wim Jiskoot, Joke Bouwstra
Journal of Pharmaceutical Sciences|April 21, 2012
Transient molten globules and metastable aggregates induced by brief exposure of a monoclonal IgG to low pHVasco Filipe, Başak Kükrer, Andrea Hawe, et al.
Pharmaceutical Research|October 26, 2017
Nanoparticulate Impurities Isolated from Pharmaceutical-Grade Sucrose Are a Potential Threat to Protein StabilityDaniel Weinbuch, Mitchel Ruigrok, Wim Jiskoot, et al.
Analytical Biochemistry|May 6, 2008
Online fluorescent dye detection method for the characterization of immunoglobulin G aggregation by size exclusion chromatography and asymmetrical flow field flow fractionationAndrea Hawe, Wolfgang Friess, Marc Sutter, et al.
Cytokine & Growth Factor Reviews|October 8, 2021
The interleukin-1 cytokine family members: Role in cancer pathogenesis and potential therapeutic applications in cancer immunotherapyBart Boersma, Wim Jiskoot, Peter Lowe, et al.
Pageof 28